Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2026-01-21

Clinical Trial Update: Domperidone Expanded Access Treatment Program

View source ↗

Summary

The Domperidone Expanded Access Treatment Program for gastroparesis has been discontinued and is no longer available.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Domperidone (domperidone)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Gastroparesis | Status: NO_LONGER_AVAILABLE